AT THE PRESENT time, indicator-dilution curves are one of the most important technics employed in the investigation of the circulation. The earliest of these studies were carried out by the rapid serial collections of blood samples and their subsequent photometric analysis.' This ingenious but cumbersome method was replaced by the continuous withdrawal of blood in front of a photoelectric cell, thus permitting the direct inscription of time-concentration curves.2 Although this approach has greatly facilitated application of the indicator-dilution principle, a number of drawbacks have remained. Most of them are related to the unavoidable physical separation of the intravascular sampling site and the external detector. Thus, the loss of blood may become significant, particularly when multiple dilution curves are necessary. Secondly, distortion of the curve results during transit from sampling site to the detector.3 Finally, it may be difficult to obtain dilution curves from the central circulation, since the blood sample must traverse a long catheter. Accordingly, considerable effort has been directed toward the development of technics that permit placement of the detector directly into the blood stream. -7 Clark and his associatess11 have recently introduced a new group of indicators, chemical reducing agents, that can be detected with intravascular platinum electrodes. This report describes the technics and instrumentation employed in this laboratory with sodium ascorbate as an indicator; particular emphasis is placed on the dilution curves ob- The system employed ( fig. 1 ) consists of a bright platinum sensing electrode incorporated on a cardiac catheter (1), or (2) threaded through a modified Cournand needle (3) , and connected to a control box (4) . A silver reference electrode (5) is placed on the skin. The control box applies +1 volt to the platinum electrode and the current flowing between the sensing and reference electrodes develops a voltage across a series resistor, and this voltage is applied to a recorder (6) . A sterilized clip lead (7) introduction of the electrode, the sensitivity on the control box is set so that the baseline current produces approximately one fifth of the full-scale deflection. The 
Results
The linearity of the electrode current with the ascorbate concentration in the blood stream was examined in dogs in which various doses of sodium ascorbate were injected intravenously. The peak amplitudes, as well as the areas beneath the arterial dilution curves were found to be linearly related to the doses ( fig. 4 ).
Sodium ascorbate dilution curves have been recorded in 25 dogs and in a total of 90 patients. There have been no febrile reactions or other detectable toxicity. In more than one half of the patients studied, the sodium ascorbate curves were compared with indoeyanine-green dye-dilution curves, with identical injection and sampling sites; the dyedilution curves were recorded immediately *Supplied as "Ascorbic Acid" by Lederle Laboratories, Pearl River, New York. Figure 3 Circuit diagram of control box.
before or after the ascorbate curves. For the paired curves, the initial portions, representing the passage of indicator through the central circulation and through any shunt in either direction, were essentially identical. It is this portion of the curve that is of diagnostic significance. In the later portions of the ascorbate curves, generated by indicator that had passed through the peripheral capillary bed and had recirculated, the peaks were smaller than the corresponding peaks in the dye curves.
Comparing the quality of the tracings on systems of equal frequency response, there were generally less artifacts coincident with the pulse in the ascorbate than in the dye curves. With the platinum electrode advanced into the thoracic vessels, these artifacts were more apparent and a signal coincident with respiration was often present, especially in tracings from the right atrium. Intracardiac electrocardiograms were present Circulation, Volume XXIV, November 1961 in high-frequency recordings. Occasional artifacts were noted coincident with movements of the patient. In some instances, the curves had to be repeated in order to distinguish a very small shunt from a respiratory artifact; otherwise these artifacts created no problems.
Ascorbate dilution curves sampled in a peripheral artery following injection into the right atrium of a patient without any cardiac shunt or valvular regurgitation are reproduced in figure 5 . In a patient with the tetralogy of Fallot, the presence of a rightto-left cardiac shunt is evidenced by the characteristic early peak in the curves reproduced in figure 6, which were obtained following injection into the right ventricle and sampling from a systemic artery. Figure 7 is an arterial dilution curve obtained following injection into a pulmonary vein of a patient with a left-to-right shunt through an atrial septal defect. There is a sudden inter- Ascorbate dilution curve obtained in a patient with an atrial septal defect following injection into a pulmonary vein (pulm. V.) and sampling from the femoral artery (F.A.). The first peak (1) represents the indicator that followed the normal circulatory path, while the second peak (2) represents the indicator that was shunted through the defect.
acterized by a large, sharp, initial deflection resulting from the reaction of the electrode to the injection of ascorbate. In the curves obtained from the pulmonary artery and the right ventricle, a second peak is apparent; this is due to the early recirculation of indicator through the shunt, and it ocurs only in areas at or distal to the site of entry of the shunt into the right side of the heart. In contrast, in the right atrium, a chamber proximal to the site of entry of the shunt, no second peak is exhibited. These curves may be compared to those reproduced in figCirculation, Volume XXIV, November 1961 ure 9, which were obtained from a patient with an atrial septal defect, in whom the abnormal shunt curve (peak 2) is present both in the curve from the right ventricle and in the curve from the right atrium, thus localizing the entry of the shunt to a point upstream to the tricuspid valve. A distinct systemic recirculation curve (peak 3) is also present.
A series of intracardiac dilution curves following peripheral vein injection in the patient with the ventricular septal defect are reproduced in figure 10 . The site of entry of the left-to-right shunt into the right ventricle is localized by the technic previously described. 13 The curves from the pulmonary artery and right ventricle exhibit a distinct interruption of the descending limb, signifying the recirculation of shunted indicator; this is not present in the curve from the right atrium, although the small degree of accompanying tricuspid regurgitation may have been responsible for the slight distortion of the descending limb of the dilution curve obtained from this chamber. Discussion Hydrogen, sodium ascorbate, and a number of other substances may be employed as indicators when platinum electrodes are used for direct intravascular detection.9 The use of hydrogen was not extensively investigated in this laboratory, since the inert foreign gases (N20 or Kr85), which are not associated with an explosive hazard, permit not only the detection and localization of small left-to-right shunts,'4 as does inhaled hydrogen, but also allow determination of the magnitude of the shunt.'5 Similarly, although hydrogen dis- solved in saline may be injected into the right side of the heart for the detection of right-toleft shunts,'0 earlier observations utilizing solutions of Kr85 in a similar manner indicated the practicality of quantifying such shunts.14' 16 It would appear likely that ascorbate equilibrates rapidly with the interstitial fluid and that a significant fraction escapes from the vascular bed during its passage through the systemic capillaries, but that only negligible amounts leave the pulmonary capillaries. Although little clinical significance should be attributed to the amplitude of the peripheral recirculation peaks of the ascorbate curves, the apparently negligible loss of this indicator from the pulmonary circulation suggests that the shunt-to-pulmonary flow ratio may be computed.
As indicated in figure 4 , when the current flowing between the electrodes is measured (rather than the potential developed), a linear relationship exists between ascorbate concentration and deflection. Work currently in progress suggests that in spite of the fact that gradual alterations in the sensitivity of the electrode take place, calibration of ascorbate dilution curves is possible, thus permitting quantification of cardiac output.
In the clinical applications of the ascorbate technic in this laboratory, the recording of V.S.D. curves from a catheter inserted directly into the heart or great vessels has been found particularly valuable. The applications have been facilitated by the availability of electrode catheters that permit both the injection and sampling of indicator through a single catheter. Although the injection of dye into the pulmonary artery and sampling of its concentration through a second catheter in the right side of the heart17 has proved to be a sensitive technic for the detection and localization of left-to-right shunts, the use The ascorbate-dilution technic has been found of particular value when the sensing electrode is incorporated into a cardiac catheter. This method permits injection and sampling of the indicator from the central circulation and greatly facilitates the study of circulatory shunts and of valvular regurgitation.
